Skip to content

PMCF Study on the Safety and Performance of CESPACE 3D

Multicenter PMCF Study on the Safety and Performance of CESPACE 3D - A Prospective Study on Total Indications

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04477447
Acronym
CATALINA
Enrollment
101
Registered
2020-07-20
Start date
2020-09-21
Completion date
2024-04-16
Last updated
2024-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Instability, Post-discectomy Syndrome, Post-traumatic Instabilities, Spondylolisthesis

Keywords

Cervical Vertebrae;, Spondylolisthesis;, Treatment Outcome;, Interbody Fusion

Brief summary

Prospective, pure data collection of all CeSPACE 3D patients in selected centers (not interventional, multicenter)

Interventions

None listed

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is minimum 18 years old * Written informed consent for the documentation of clinical and radiological results * Patient's indication according to IFU * Patient is not pregnant

Exclusion criteria

• Patient is not willing or able to participate at the follow-up examination

Design outcomes

Primary

MeasureTime frameDescription
Change of Neck Specific Disability measured by Neck Disability Index (NDI)preoperative, 12 months postoperativeThe NDI is designed to measure neck-specific disability. The questionnaire has 10 items to measure patient-reported disability secondary to neck pain and activities of daily living including personal care, lifting, reading, headaches, concentration, work status, driving, sleeping and recreation and patients rate their status from 0 (best) to 5 (worst imaginable). Individual item responses are summed to a total score, where 0 points indicate no activity limitations and 50 points indicate complete activity limitation.

Secondary

MeasureTime frameDescription
development of radiological outcomepreoperatively and at one follow-up- assessment after a minimum of one year postoperativelyif provided in the clinical standard; e.g. fusion, implant subsidence, implant migration)
JOA scorepreoperatively and at one follow-up- assessment after a minimum of one year postoperativelyThe Japanese Orthopaedic Association (JOA) score is a widely used tool to assess the severity of clinical symptoms in patients with cervical compressive myelopathy. Motor function (Upper extremity/Lower extremity); Sensory (Upper extremity/lower extremity/trunk); Bladder function. The Score reaches a maximum of 17 and a Minimum of 0 points.
development of EQ-5D-5Lpreoperatively and at one follow-up- assessment after a minimum of one year postoperativelyThe descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
Rate of AE/SAEspreoperatively, intraoperatively and at one follow-up- assessment after a minimum of one year postoperativelyRate of AE/SAEs during the postoperative course
Patient Satisfaction with Treatment Outcomeat one follow-up- assessment after a minimum of one year postoperativelyPatient satisfaction with Outcome of surgery documented in two aspects: is the Patient satisfied (four Point scale: very satisfied, satisfied, unsatisfied, very unsatisfied) and would the Patient like to undergo surgery again (yes, no, not willing to say)
Pain (VAS)preoperatively and at one follow-up- assessment after a minimum of one year postoperativelyThe visual analogue scale (VAS) is a scale used to determine the pain intensity experienced by individuals. It consists of a line, approximately 10-15 cm in length, with the left side signifying no pain with a smiling face image and the right side signifying the worst pain ever with a frowning face image.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026